4 questions lodged at 2026 Opthea (OPT) virtual EGM
July 3, 2026
Below is the text of the 4 written questions submitted at the 8 minute Opthea (OPT) 10am virtual EGM via Computershare platform on July 3, 2026 to approve change of name to Ceryvyn Therapeutics. See notice of meeting. Market cap $20.5m on EGM day. See ridiculous 12 questions asked at 2022 AGM. The proxies were not disclosed early in the formal addresses and the resolution was passed with 99% support.
Q1. How much overall has it cost us to hold this EGM and how much does it cost to use the excellent Computershare online meeting platform? Why didn't we wait until the next AGM which has to be held no later than the end of November?
Answer: Watch this video of executive chair Dr Jeremy Levin failing to deal with this question, plus this video of him closing the meeting after just 8 minutes without responding to 3 of my 4 questions. Hopeless transparency and brazen censorship.
Q2. Why did we settle on Ceryvyn Therapeutics as our new name. It's hard to spell. What does it mean? What other options did we consider and did we pay any external market research firm to assist with the process. Does ASX charge anything to change a company's name and code?
Answer: The chair provided a lengthy response on the fantastic effort by its team to come up with the new name and the response included that no external marketing agency was used and the ASX does not charge for a name change. Watch video of exchange via Twitter.
Q3. How many of our circa 9,000 shareholders voted by proxy on this resolution and what was the turn out in terms of percentage of issued capital? Were there any material protest votes and will you include the headcount data in the poll results lodged with the ASX so we can see the sentiment of smaller shareholders as well as the position taken by our largest voting shareholders, such as Regal, which will dominate the outcome?
Answer: Watch this video of executive chair Dr Jeremy Levin failing to deal with this question, plus this video of him closing the meeting after just 8 minutes without responding to 3 of my 4 questions. Hopeless transparency and brazen censorship.
Q4. Our latest audited accounts show that we have a staggering $753 million in accumulated losses and net assets of just $33 million, which is above out current market cap of $20.5m. Most companies give up before hitting $200m in losses. Why did we keep going? How much is the name change designed to bury the past and those enormous losses, in an attempt to start afresh in order to salvage something from the value destruction inferno? And with the benefit of hindsight, what should we have done differently to give long-standing shareholders a better experience?
Answer: Watch this video of executive chair Dr Jeremy Levin failing to deal with this question, plus this video of him closing the meeting after just 8 minutes without responding to 3 of my 4 questions. Hopeless transparency and brazen censorship.
Copyright © 2026 The Mayne Report. All rights reserved
